Shanghai Bima Life Sciences
PrivateLast Round
Series B
Jan 4, 2022
Est. Valuation
$30.8M
Total Funding Raised
$50M
Company Overview
Shanghai Bima Life Sciences is a biotechnology company that provides a proteomics detection platform based on antibody affinity assay.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Bima Life Sciences Comparables
Compare Shanghai Bima Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| TriApex Laboratories | 81% | |
| Prisys Biotechnology Co., Ltd. | 81% | |
| Shanghai Medicilon Inc. | 81% | |
Shanghai Bima Life Sciences Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jan 4, 2022 | ||||
| Series A Extension | Aug 7, 2020 | ||||
| Series A | Jan 1, 2019 | ||||
| Angel | Jun 1, 2017 |
Shanghai Bima Life Sciences Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Photon Fund | Series B |
| Sincere Capital | Series B |
| Highlight Capital | Series B |
| Kaitai Capital | Series A Extension, Series A |
| J-One Capital Invest | Series A Extension |
| Shengshan Asset Management | Series A |
| Viva Biotech | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 4, 2022
$30M round led by Highlight Capital and Photon Fund.
- Jun 1, 2017
Completed an Angel round of funding.
Shanghai Bima Life Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Bima Life Sciences's valuation, stock price, and market status.